Frontiers in Oncology | Breast Cancer

Original Research

Published on 28 Jan 2025

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications

in Breast Cancer

Hossein Schandiz
Lorant Farkas
Daehoon Park
Yan Liu
Solveig N. Andersen
Torill Sauer
Jürgen Geisler

Frontiers in Oncology

doi 10.3389/fonc.2025.1467664

2,037 views

Original Research

Published on 28 Jan 2025

Asymptotic analysis of mathematical model describing a new treatment of breast cancer using AZD9496 and palbociclib

in Breast Cancer

Ophir Nave

Frontiers in Oncology

doi 10.3389/fonc.2024.1482223

832 views

Original Research

Published on 27 Jan 2025

RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer

in Breast Cancer

Charlotte K. Kindt
Sidse Ehmsen
Sofie Traynor
Benedetta Policastro
Nikoline Nissen
Mie K. Jakobsen
Monique F. Hundebøl
Lene E. Johansen
Martin Bak
Elsa Arbajian

Frontiers in Oncology

doi 10.3389/fonc.2024.1497093

2,025 views
1 citation

Original Research

Published on 27 Jan 2025

Multi-institutional evaluation comparing guidance from International Ki67 Working Group vs National Health Commission of China on immunohistochemistry-based Ki67 assessment alongside the Quantitative Dot Blot method

in Breast Cancer

Yin Wang
Jiarui Zou
Qinghua Cao
Guihong Dai
Panhong Fan
Xue Gong
Jinyan Jiang
Yanqing Kong
Chao Liu
Chunhui Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1510273

884 views

Original Research

Published on 24 Jan 2025

Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer

in Breast Cancer

Qin Fang
Shuru Chen
Xiaoyue Chen
Wei Zou
Di Chen
Yukang Huang
Chucheng Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1480461

1,274 views

Original Research

Published on 22 Jan 2025

Nomogram prediction of overall survival in breast cancer patients post-surgery: integrating SEER database and multi-center evidence from China

in Breast Cancer

Yufen Zheng
Yuan Yuan
Minya Jin
Chunlong Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1470515

1,148 views

Case Report

Published on 21 Jan 2025

Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan

in Breast Cancer

Ünal Metin Tokat
Ashkan Adibi
Esranur Aydın
Şevval Nur Bilgiç
Eylül Özgü
Onur Tutar
Mutlu Demiray

Frontiers in Oncology

doi 10.3389/fonc.2024.1484750

2,466 views
2 citations

Original Research

Published on 21 Jan 2025

Prioritizing breast cancer surgeries: insights from the KRONOS SCORE

in Breast Cancer

Lucía Navarro
Luis Perez-Bartivas
David Ponferrada
Javier Cejas
Juan Adrián Camús
Natalia Rangel
Maria Porras
Cristina Morales Estevez
Amalia Palacios Eito
Pilar Rioja

Frontiers in Oncology

doi 10.3389/fonc.2024.1465154

1,131 views

Original Research

Published on 21 Jan 2025

A multi-centre, randomised trial for diagnostic efficacy of the automatic breast volume scanner ultrasound for breast cancer screening in China

in Breast Cancer

Ying Xu
Yali Xu
Songjie Shen
Feng Mao
Xiaohui Zhang
Yanna Zhang
Yan Lin
Yidong Zhou
Qiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1421425

874 views

Original Research

Published on 20 Jan 2025

Cyanoacrylate glue in breast surgery: the GLUBREAST Trial

in Breast Cancer

Emanuela Esposito
Claudio Siani
Ivana Donzelli
Anna Crispo
Sergio Coluccia
Piergiacomo Di Gennaro
Assunta Luongo
Franca Avino
Alfredo Fucito
Ugo Marone

Frontiers in Oncology

doi 10.3389/fonc.2024.1473157

1,028 views

Original Research

Published on 20 Jan 2025

Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy

in Breast Cancer

Jie Ma
Hongtao Wang
Zhengwei Gui
Yuanrong Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1490073

1,073 views

Original Research

Published on 17 Jan 2025

Needle tracking and segmentation in breast ultrasound imaging based on spatio-temporal memory network

in Breast Cancer

Qiyun Zhang
Jiawei Chen
Jinhong Wang
Haolin Wang
Yi He
Bin Li
Zhemin Zhuang
Huancheng Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1519536

820 views

Original Research

Published on 16 Jan 2025

Enhanced detection of circulating tumor cells using a MUC1 promoter-driven recombinant adenovirus

in Breast Cancer

Cheng Wang
Huihui Gu
Jia Cai
Chuandong Zhu
Qin Zheng
Hanfeng Xu
Lixue Wang
Yuan Wan

Frontiers in Oncology

doi 10.3389/fonc.2024.1506968

1,075 views

Original Research

Published on 15 Jan 2025

Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus

in Breast Cancer

Emad Dawoud
Fathi Azribi
Aref Chehal
Shaheenah Dawood
Syed Hammad Tirmazy
Dina Hamza
Hassan Jaafar
Hussam Marashi

Frontiers in Oncology

doi 10.3389/fonc.2024.1443962

1,727 views

Original Research

Published on 10 Jan 2025

EIF4A3-induced circ_0022382 promotes breast cancer cell progression through the let-7a-5p/PI3K/AKT/mTOR signaling pathway and SLC7A11 axis

in Breast Cancer

Wei Liu
Jun Zhang
Jiawen Zhang
Yu Ye
Jianqin Zhu
Qiwen Yu
Tao Li
Xiaochun Sun
Huabiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1476731

1,491 views
1 citation

Case Report

Published on 08 Jan 2025

Case report: Illustrating associated malignancies in Paget’s disease using contrast-enhanced mammography

in Breast Cancer

Luciano Mariano
Luca Nicosia
Anna Bozzini
Filippo Pesapane
Francesca Magnoni
Giovanni Mazzarol
Lorenza Meneghetti
Adriana Sorce
Enrico Cassano

Frontiers in Oncology

doi 10.3389/fonc.2024.1497506

664 views